JAKARTA (Reuters) - Indonesia's government has taken steps to over-ride patents for HIV drugs, following the lead of other Asian states that have allowed the production of cheap generic drugs that cut into the sales of global pharmaceutical companies. President Susilo Bambang Yudhoyono quietly issued a decree last month authorizing the use of patents for seven HIV/AIDS and hepatitis medicines held by the likes of Merck & Co, GlaxoSmithKline, Bristol-Myers Squibb, Abbott and Gilead. The companies affected did not provide immediate comment. ... Courtesy of Yahoo News
No comments:
Post a Comment